A Study of Genetic Profiling of Peyronie's Disease Patients


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 18-008865
    Sponsor Protocol Number: 18-008865

About this study

The purpose of this study is to provide comprehensive genetic profiling of Peyronie's Disease (PD) patients, discover candidate genes associated with the disease, and to compare the identified candidate genetic mutations/variations with familial and non-familial cases.




Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Men aged 45-70 years old (for initial screening); 
  • Diagnosis of Peyronie's Disease (PD); OR 
  • Male family members of men with PD (>18 years old).

Exclusion Criteria: 

  • None.


Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Landon Trost, M.D.

Open for enrollment

Contact information:

Tessa Kroeninger CCRP



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer